Skip to main content
PMC home page
Gut logoLink to Gut
. 2001 Feb;48(2):143–147. doi: 10.1136/gut.48.2.143

Inherited predisposition to pancreatic cancer

E EFTHIMIOU 1, T CRNOGORAC-JURCEVI 1, N LEMOINE 1, T BRENTNALL 1
PMCID: PMC1728218  PMID: 11156628

Full Text

The Full Text of this article is available as a PDF (123.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamek H. E., Albert J., Breer H., Weitz M., Schilling D., Riemann J. F. Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study. Lancet. 2000 Jul 15;356(9225):190–193. doi: 10.1016/S0140-6736(00)02479-X. [DOI] [PubMed] [Google Scholar]
  2. Baron P. L., Aabakken L. E., Cole D. J., LeVeen M. B., Baron L. F., Daniel D. M., Cunningham J. T., Hawes R. H., Adams D. B., Hoffman B. J. Differentiation of benign from malignant pancreatic masses by endoscopic ultrasound. Ann Surg Oncol. 1997 Dec;4(8):639–643. doi: 10.1007/BF02303748. [DOI] [PubMed] [Google Scholar]
  3. Bergman W., Watson P., de Jong J., Lynch H. T., Fusaro R. M. Systemic cancer and the FAMMM syndrome. Br J Cancer. 1990 Jun;61(6):932–936. doi: 10.1038/bjc.1990.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bluemke D. A., Cameron J. L., Hruban R. H., Pitt H. A., Siegelman S. S., Soyer P., Fishman E. K. Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology. 1995 Nov;197(2):381–385. doi: 10.1148/radiology.197.2.7480681. [DOI] [PubMed] [Google Scholar]
  5. Boardman L. A., Thibodeau S. N., Schaid D. J., Lindor N. M., McDonnell S. K., Burgart L. J., Ahlquist D. A., Podratz K. C., Pittelkow M., Hartmann L. C. Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med. 1998 Jun 1;128(11):896–899. doi: 10.7326/0003-4819-128-11-199806010-00004. [DOI] [PubMed] [Google Scholar]
  6. Borg A., Sandberg T., Nilsson K., Johannsson O., Klinker M., Måsbäck A., Westerdahl J., Olsson H., Ingvar C. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst. 2000 Aug 2;92(15):1260–1266. doi: 10.1093/jnci/92.15.1260. [DOI] [PubMed] [Google Scholar]
  7. Brentnall T. A., Bronner M. P., Byrd D. R., Haggitt R. C., Kimmey M. B. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med. 1999 Aug 17;131(4):247–255. doi: 10.7326/0003-4819-131-4-199908170-00003. [DOI] [PubMed] [Google Scholar]
  8. Brentnall T. A. Cancer surveillance of patients from familial pancreatic cancer kindreds. Med Clin North Am. 2000 May;84(3):707–718. doi: 10.1016/s0025-7125(05)70253-4. [DOI] [PubMed] [Google Scholar]
  9. Danes B. S., Lynch H. T. A familial aggregation of pancreatic cancer. An in vitro study. JAMA. 1982 May 28;247(20):2798–2802. [PubMed] [Google Scholar]
  10. Ehrenthal D., Haeger L., Griffin T., Compton C. Familial pancreatic adenocarcinoma in three generations. A case report and a review of the literature. Cancer. 1987 May 1;59(9):1661–1664. doi: 10.1002/1097-0142(19870501)59:9<1661::aid-cncr2820590923>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  11. Evans J. P., Burke W., Chen R., Bennett R. L., Schmidt R. A., Dellinger E. P., Kimmey M., Crispin D., Brentnall T. A., Byrd D. R. Familial pancreatic adenocarcinoma: association with diabetes and early molecular diagnosis. J Med Genet. 1995 May;32(5):330–335. doi: 10.1136/jmg.32.5.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fernandez E., La Vecchia C., D'Avanzo B., Negri E., Franceschi S. Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 1994 Apr-May;3(3):209–212. [PubMed] [Google Scholar]
  13. Ferrucci J. T. MRI and MRCP in pancreaticobiliary malignancy. Ann Oncol. 1999;10 (Suppl 4):18–19. doi: 10.1023/a:1008364130766. [DOI] [PubMed] [Google Scholar]
  14. Finch M. D., Howes N., Ellis I., Mountford R., Sutton R., Raraty M., Neoptolemos J. P. Hereditary pancreatitis and familial pancreatic cancer. Digestion. 1997;58(6):564–569. doi: 10.1159/000201502. [DOI] [PubMed] [Google Scholar]
  15. Furukawa H., Muramatsu Y., Moriyama N. Does MR cholangiopancreatography contribute to the early diagnosis of pancreatic carcinoma? Pancreas. 1999 Nov;19(4):408–409. doi: 10.1097/00006676-199911000-00014. [DOI] [PubMed] [Google Scholar]
  16. Ghadirian P., Boyle P., Simard A., Baillargeon J., Maisonneuve P., Perret C. Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Int J Pancreatol. 1991 Nov-Dec;10(3-4):183–196. doi: 10.1007/BF02924156. [DOI] [PubMed] [Google Scholar]
  17. Giardiello F. M., Welsh S. B., Hamilton S. R., Offerhaus G. J., Gittelsohn A. M., Booker S. V., Krush A. J., Yardley J. H., Luk G. D. Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med. 1987 Jun 11;316(24):1511–1514. doi: 10.1056/NEJM198706113162404. [DOI] [PubMed] [Google Scholar]
  18. Goggins M., Hruban R. H., Kern S. E. BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. Am J Pathol. 2000 May;156(5):1767–1771. doi: 10.1016/S0002-9440(10)65047-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Goggins M., Offerhaus G. J., Hilgers W., Griffin C. A., Shekher M., Tang D., Sohn T. A., Yeo C. J., Kern S. E., Hruban R. H. Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. Am J Pathol. 1998 Jun;152(6):1501–1507. [PMC free article] [PubMed] [Google Scholar]
  20. Goggins M., Schutte M., Lu J., Moskaluk C. A., Weinstein C. L., Petersen G. M., Yeo C. J., Jackson C. E., Lynch H. T., Hruban R. H. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res. 1996 Dec 1;56(23):5360–5364. [PubMed] [Google Scholar]
  21. Goldstein A. M., Fraser M. C., Struewing J. P., Hussussian C. J., Ranade K., Zametkin D. P., Fontaine L. S., Organic S. M., Dracopoli N. C., Clark W. H., Jr Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Engl J Med. 1995 Oct 12;333(15):970–974. doi: 10.1056/NEJM199510123331504. [DOI] [PubMed] [Google Scholar]
  22. Goldstein A. M., Struewing J. P., Chidambaram A., Fraser M. C., Tucker M. A. Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations. J Natl Cancer Inst. 2000 Jun 21;92(12):1006–1010. doi: 10.1093/jnci/92.12.1006. [DOI] [PubMed] [Google Scholar]
  23. Hall P. A., Lemoine N. R. Models of pancreatic cancer. Cancer Surv. 1993;16:135–155. [PubMed] [Google Scholar]
  24. Heinmöller E., Dietmaier W., Zirngibl H., Heinmöller P., Scaringe W., Jauch K. W., Hofstädter F., Rüschoff J. Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. Am J Pathol. 2000 Jul;157(1):83–92. doi: 10.1016/S0002-9440(10)64520-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hemminki A., Markie D., Tomlinson I., Avizienyte E., Roth S., Loukola A., Bignell G., Warren W., Aminoff M., Höglund P. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature. 1998 Jan 8;391(6663):184–187. doi: 10.1038/34432. [DOI] [PubMed] [Google Scholar]
  26. Hemminki A., Tomlinson I., Markie D., Järvinen H., Sistonen P., Björkqvist A. M., Knuutila S., Salovaara R., Bodmer W., Shibata D. Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet. 1997 Jan;15(1):87–90. doi: 10.1038/ng0197-87. [DOI] [PubMed] [Google Scholar]
  27. Hizawa K., Iida M., Matsumoto T., Kohrogi N., Kinoshita H., Yao T., Fujishima M. Cancer in Peutz-Jeghers syndrome. Cancer. 1993 Nov 1;72(9):2777–2781. doi: 10.1002/1097-0142(19931101)72:9<2777::aid-cncr2820720940>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  28. Hruban R. H., Petersen G. M., Goggins M., Tersmette A. C., Offerhaus G. J., Falatko F., Yeo C. J., Kern S. E. Familial pancreatic cancer. Ann Oncol. 1999;10 (Suppl 4):69–73. [PubMed] [Google Scholar]
  29. Iguchi H., Sugano K., Fukayama N., Ohkura H., Sadamoto K., Ohkoshi K., Seo Y., Tomoda H., Funakoshi A., Wakasugi H. Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer. Gastroenterology. 1996 Jan;110(1):221–226. doi: 10.1053/gast.1996.v110.pm8536860. [DOI] [PubMed] [Google Scholar]
  30. Jenne D. E., Reimann H., Nezu J., Friedel W., Loff S., Jeschke R., Müller O., Back W., Zimmer M. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet. 1998 Jan;18(1):38–43. doi: 10.1038/ng0198-38. [DOI] [PubMed] [Google Scholar]
  31. Keogan M. T., Tyler D., Clark L., Branch M. S., McDermott V. G., DeLong D. M., Coleman R. E. Diagnosis of pancreatic carcinoma: role of FDG PET. AJR Am J Roentgenol. 1998 Dec;171(6):1565–1570. doi: 10.2214/ajr.171.6.9843289. [DOI] [PubMed] [Google Scholar]
  32. Kondo H., Sugano K., Fukayama N., Hosokawa K., Ohkura H., Ohtsu A., Mukai K., Yoshida S. Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas. Cancer. 1997 Mar 1;79(5):900–905. doi: 10.1002/(sici)1097-0142(19970301)79:5<900::aid-cncr5>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  33. Kondo H., Sugano K., Fukayama N., Kyogoku A., Nose H., Shimada K., Ohkura H., Ohtsu A., Yoshida S., Shimosato Y. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma. Cancer. 1994 Mar 15;73(6):1589–1594. doi: 10.1002/1097-0142(19940315)73:6<1589::aid-cncr2820730609>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  34. Lal G., Liu G., Schmocker B., Kaurah P., Ozcelik H., Narod S. A., Redston M., Gallinger S. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res. 2000 Jan 15;60(2):409–416. [PubMed] [Google Scholar]
  35. Lal G., Liu L., Hogg D., Lassam N. J., Redston M. S., Gallinger S. Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations. Genes Chromosomes Cancer. 2000 Apr;27(4):358–361. [PubMed] [Google Scholar]
  36. Lamerz R. Role of tumour markers, cytogenetics. Ann Oncol. 1999;10 (Suppl 4):145–149. [PubMed] [Google Scholar]
  37. Lemoine N. R. Molecular advances in pancreatic cancer. Digestion. 1997;58(6):550–556. doi: 10.1159/000201500. [DOI] [PubMed] [Google Scholar]
  38. Levin B. An overview of preventive strategies for pancreatic cancer. Ann Oncol. 1999;10 (Suppl 4):193–196. [PubMed] [Google Scholar]
  39. Loperfido S., Angelini G., Benedetti G., Chilovi F., Costan F., De Berardinis F., De Bernardin M., Ederle A., Fina P., Fratton A. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc. 1998 Jul;48(1):1–10. doi: 10.1016/s0016-5107(98)70121-x. [DOI] [PubMed] [Google Scholar]
  40. Lowenfels A. B., Maisonneuve P., Cavallini G., Ammann R. W., Lankisch P. G., Andersen J. R., Dimagno E. P., Andrén-Sandberg A., Domellöf L. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med. 1993 May 20;328(20):1433–1437. doi: 10.1056/NEJM199305203282001. [DOI] [PubMed] [Google Scholar]
  41. Lowenfels A. B., Maisonneuve P., DiMagno E. P., Elitsur Y., Gates L. K., Jr, Perrault J., Whitcomb D. C. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst. 1997 Mar 19;89(6):442–446. doi: 10.1093/jnci/89.6.442. [DOI] [PubMed] [Google Scholar]
  42. Lynch H. T., Fitzsimmons M. L., Smyrk T. C., Lanspa S. J., Watson P., McClellan J., Lynch J. F. Familial pancreatic cancer: clinicopathologic study of 18 nuclear families. Am J Gastroenterol. 1990 Jan;85(1):54–60. [PubMed] [Google Scholar]
  43. Lynch H. T., Fusaro L., Lynch J. F. Familial pancreatic cancer: a family study. Pancreas. 1992;7(5):511–515. doi: 10.1097/00006676-199209000-00001. [DOI] [PubMed] [Google Scholar]
  44. Lynch H. T., Fusaro R. M., Kimberling W. J., Lynch J. F., Danes B. S. Familial atypical multiple mole-melanoma (FAMMM) syndrome: segregation analysis. J Med Genet. 1983 Oct;20(5):342–344. doi: 10.1136/jmg.20.5.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Lynch H. T., Smyrk T., Kern S. E., Hruban R. H., Lightdale C. J., Lemon S. J., Lynch J. F., Fusaro L. R., Fusaro R. M., Ghadirian P. Familial pancreatic cancer: a review. Semin Oncol. 1996 Apr;23(2):251–275. [PubMed] [Google Scholar]
  46. Martin S. P., Ulrich C. D., 2nd Pancreatic cancer surveillance in a high-risk cohort. Is it worth the cost? Med Clin North Am. 2000 May;84(3):739-47, xii-xiii. doi: 10.1016/s0025-7125(05)70255-8. [DOI] [PubMed] [Google Scholar]
  47. Ozçelik H., Schmocker B., Di Nicola N., Shi X. H., Langer B., Moore M., Taylor B. R., Narod S. A., Darlington G., Andrulis I. L. Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat Genet. 1997 May;16(1):17–18. doi: 10.1038/ng0597-17. [DOI] [PubMed] [Google Scholar]
  48. Phelan C. M., Lancaster J. M., Tonin P., Gumbs C., Cochran C., Carter R., Ghadirian P., Perret C., Moslehi R., Dion F. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat Genet. 1996 May;13(1):120–122. doi: 10.1038/ng0596-120. [DOI] [PubMed] [Google Scholar]
  49. Rivera J. A., Rall C. J., Graeme-Cook F., Fernández-del Castillo C., Shu P., Lakey N., Tepper R., Rattner D. W., Warshaw A. L., Rustgi A. K. Analysis of K-ras oncogene mutations in chronic pancreatitis with ductal hyperplasia. Surgery. 1997 Jan;121(1):42–49. doi: 10.1016/s0039-6060(97)90181-1. [DOI] [PubMed] [Google Scholar]
  50. Roa B. B., Boyd A. A., Volcik K., Richards C. S. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet. 1996 Oct;14(2):185–187. doi: 10.1038/ng1096-185. [DOI] [PubMed] [Google Scholar]
  51. Schnall S. F., Macdonald J. S. Chemotherapy of adenocarcinoma of the pancreas. Semin Oncol. 1996 Apr;23(2):220–228. [PubMed] [Google Scholar]
  52. Silverman D. T., Dunn J. A., Hoover R. N., Schiffman M., Lillemoe K. D., Schoenberg J. B., Brown L. M., Greenberg R. S., Hayes R. B., Swanson G. M. Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst. 1994 Oct 19;86(20):1510–1516. doi: 10.1093/jnci/86.20.1510. [DOI] [PubMed] [Google Scholar]
  53. Silverman D. T., Schiffman M., Everhart J., Goldstein A., Lillemoe K. D., Swanson G. M., Schwartz A. G., Brown L. M., Greenberg R. S., Schoenberg J. B. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer. 1999 Aug;80(11):1830–1837. doi: 10.1038/sj.bjc.6690607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Steinberg W. M., Barkin J., Bradley E. L., 3rd, DiMagno E., Layer P. Workup of a patient with familial pancreatic cancer. Pancreas. 1999 Apr;18(3):219–224. doi: 10.1097/00006676-199904000-00001. [DOI] [PubMed] [Google Scholar]
  55. Su G. H., Hruban R. H., Bansal R. K., Bova G. S., Tang D. J., Shekher M. C., Westerman A. M., Entius M. M., Goggins M., Yeo C. J. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol. 1999 Jun;154(6):1835–1840. doi: 10.1016/S0002-9440(10)65440-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Suehara N., Mizumoto K., Muta T., Tominaga Y., Shimura H., Kitajima S., Hamasaki N., Tsuneyoshi M., Tanaka M. Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states. Clin Cancer Res. 1997 Jun;3(6):993–998. [PubMed] [Google Scholar]
  57. Tada M., Omata M., Kawai S., Saisho H., Ohto M., Saiki R. K., Sninsky J. J. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res. 1993 Jun 1;53(11):2472–2474. [PubMed] [Google Scholar]
  58. Thorlacius S., Olafsdottir G., Tryggvadottir L., Neuhausen S., Jonasson J. G., Tavtigian S. V., Tulinius H., Ogmundsdottir H. M., Eyfjörd J. E. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet. 1996 May;13(1):117–119. doi: 10.1038/ng0596-117. [DOI] [PubMed] [Google Scholar]
  59. Tonin P., Weber B., Offit K., Couch F., Rebbeck T. R., Neuhausen S., Godwin A. K., Daly M., Wagner-Costalos J., Berman D. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med. 1996 Nov;2(11):1179–1183. doi: 10.1038/nm1196-1179. [DOI] [PubMed] [Google Scholar]
  60. Uehara H., Nakaizumi A., Tatsuta M., Baba M., Takenaka A., Uedo N., Sakai N., Yano H., Iishi H., Ohigashi H. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations. Am J Gastroenterol. 1999 Sep;94(9):2513–2518. doi: 10.1111/j.1572-0241.1999.01386.x. [DOI] [PubMed] [Google Scholar]
  61. Watanabe H., Ha A., Hu Y. X., Ohtsubo K., Yamaguchi Y., Motoo Y., Okai T., Toya D., Tanaka N., Sawabu N. K-ras mutations in duodenal aspirate without secretin stimulation for screening of pancreatic and biliary tract carcinoma. Cancer. 1999 Oct 15;86(8):1441–1448. [PubMed] [Google Scholar]
  62. Watanabe H., Sawabu N., Ohta H., Satomura Y., Yamakawa O., Motoo Y., Okai T., Takahashi H., Wakabayashi T. Identification of K-ras oncogene mutations in the pure pancreatic juice of patients with ductal pancreatic cancers. Jpn J Cancer Res. 1993 Sep;84(9):961–965. doi: 10.1111/j.1349-7006.1993.tb00185.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Whelan A. J., Bartsch D., Goodfellow P. J. Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N Engl J Med. 1995 Oct 12;333(15):975–977. doi: 10.1056/NEJM199510123331505. [DOI] [PubMed] [Google Scholar]
  64. Whitcomb D. C., Gorry M. C., Preston R. A., Furey W., Sossenheimer M. J., Ulrich C. D., Martin S. P., Gates L. K., Jr, Amann S. T., Toskes P. P. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet. 1996 Oct;14(2):141–145. doi: 10.1038/ng1096-141. [DOI] [PubMed] [Google Scholar]
  65. Zimny M., Buell U. 18FDG-positron emission tomography in pancreatic cancer. Ann Oncol. 1999;10 (Suppl 4):28–32. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES